The Cooper Companies, Inc. logo

The Cooper Companies, Inc. (COO)

Market Closed
27 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
70. 29
-0.02
-0.0284%
Pre Market
$
71. 88
+1.59 +2.2621%
13.71B Market Cap
- P/E Ratio
0.06% Div Yield
2.15M Volume
- Eps
$ 70.31
Previous Close
Add Transaction
Day Range
70.26 71.63
Year Range
58.89 89.83
Want to track COO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
The Cooper Companies (COO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

The Cooper Companies (COO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

The Cooper Companies (COO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks | 11 months ago
Cooper Companies' Innovation Fuels Growth Amid Macro Headwinds

Cooper Companies' Innovation Fuels Growth Amid Macro Headwinds

COO leans on innovation and diversification to fuel growth, but fertility softness, tariffs and inventory headwinds weigh on near-term outlook.

Zacks | 11 months ago
All You Need to Know About The Cooper Companies (COO) Rating Upgrade to Buy

All You Need to Know About The Cooper Companies (COO) Rating Upgrade to Buy

The Cooper Companies (COO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Zacks | 11 months ago
COO or SAUHY: Which Is the Better Value Stock Right Now?

COO or SAUHY: Which Is the Better Value Stock Right Now?

Investors looking for stocks in the Medical - Dental Supplies sector might want to consider either The Cooper Companies (COO) or Straumann Holding AG (SAUHY). But which of these two stocks presents investors with the better value opportunity right now?

Zacks | 11 months ago
COO Stock Declines Despite Strong Core Growth Amid Fertility Woes

COO Stock Declines Despite Strong Core Growth Amid Fertility Woes

The Cooper Companies grows margins and premium products, but fertility softness, inventory cuts, and tariffs weigh on the near-term outlook.

Zacks | 1 year ago
Medicus Pharma names Andrew Smith as COO, advances BCC and prostate drug studies

Medicus Pharma names Andrew Smith as COO, advances BCC and prostate drug studies

Medicus Pharma (NASDAQ:MDCX) said on Monday it has appointed Andrew Smith as chief operating officer, bringing on board a seasoned asset management executive as the company accelerates its clinical development programs in the US, Europe, and the Middle East. Smith, who most recently served as CEO of SR Asset Management until its sale in 2024, brings over 30 years of experience in financial and operational leadership.

Proactiveinvestors | 1 year ago
3 Oversold Stocks Flashing Bullish Reversal Signals

3 Oversold Stocks Flashing Bullish Reversal Signals

When it comes to short-term trading signals, few indicators are as closely tracked as the Relative Strength Index (RSI). A stock's RSI measures the speed and magnitude of its recent price movements.

Marketbeat | 1 year ago
Why The Cooper Companies (COO) is a Top Growth Stock for the Long-Term

Why The Cooper Companies (COO) is a Top Growth Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 1 year ago
Understanding The Cooper Companies (COO) Reliance on International Revenue

Understanding The Cooper Companies (COO) Reliance on International Revenue

Explore The Cooper Companies' (COO) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.

Zacks | 1 year ago
COO Q2 Earnings Signal Growth and Caution: How to Play the Stock?

COO Q2 Earnings Signal Growth and Caution: How to Play the Stock?

Cooper Companies COO delivered a solid fiscal second quarter performance in 2025, surpassing analyst expectations with $1 billion in revenue (up 6.3% YoY) and adjusted earnings per share (EPS) of 96 cents (up 14% YoY). Despite persistent macroeconomic headwinds and a slightly softened outlook for industry growth, management reaffirmed confidence in its core product momentum and operational leverage.

Zacks | 1 year ago
Top Stock Movers Now: Regeneron, Ulta Beauty, Cooper, and More

Top Stock Movers Now: Regeneron, Ulta Beauty, Cooper, and More

U.S. equities were lower at midday as the market focused on the future of U.S.-China trade. The Dow Jones Industrial Average, S&P 500, and Nasdaq all lost ground.

Investopedia | 1 year ago
COO Q2 Earnings Beat, 2025 Sales Outlook Tightened, Stock Down

COO Q2 Earnings Beat, 2025 Sales Outlook Tightened, Stock Down

COO's fiscal Q2 earnings and sales beat market expectations on the back of strong growth. Improvement in operating margin bodes well.

Zacks | 1 year ago
Loading...
Load More